TD Cowen analysts increased their price target for Spring Works Therapeutics (NASDAQ:SWTX) shares to $66.00 from $63.00, while maintaining a "Buy" rating on the stock. The company's shares, currently ...
With a heartbeat abortion ban solidly in place in South Carolina, lawyers for the state and Planned Parenthood return to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback